The Ku heterodimer: function in DNA repair and beyond

Mutation Research. Reviews in Mutation Research
Victoria L Fell, Caroline Schild-Poulter

Abstract

Ku is an abundant, highly conserved DNA binding protein found in both prokaryotes and eukaryotes that plays essential roles in the maintenance of genome integrity. In eukaryotes, Ku is a heterodimer comprised of two subunits, Ku70 and Ku80, that is best characterized for its central role as the initial DNA end binding factor in the "classical" non-homologous end joining (C-NHEJ) pathway, the main DNA double-strand break (DSB) repair pathway in mammals. Ku binds double-stranded DNA ends with high affinity in a sequence-independent manner through a central ring formed by the intertwined strands of the Ku70 and Ku80 subunits. At the break, Ku directly and indirectly interacts with several C-NHEJ factors and processing enzymes, serving as the scaffold for the entire DNA repair complex. There is also evidence that Ku is involved in signaling to the DNA damage response (DDR) machinery to modulate the activation of cell cycle checkpoints and the activation of apoptosis. Interestingly, Ku is also associated with telomeres, where, paradoxically to its DNA end-joining functions, it protects the telomere ends from being recognized as DSBs, thereby preventing their recombination and degradation. Ku, together with the silent information reg...Continue Reading

References

Oct 25, 1991·Nucleic Acids Research·S Paillard, F Strauss
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M C Dabauvalle, W W Franke
Sep 25, 1994·Nucleic Acids Research·M OnoJ D Capra
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·W K Rathmell, G Chu
Oct 29, 1993·Biochemical and Biophysical Research Communications·W Kaczmarski, S A Khan
Mar 1, 1997·Molecular and Cellular Biology·B K SingletonP A Jeggo
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·R B CaryD J Chen
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y GuF W Alt
Sep 18, 1997·The Journal of Experimental Medicine·H OuyangG C Li
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·A NussenzweigG C Li
May 23, 1998·Science·S GravelR J Wellinger
Jun 24, 1998·The Journal of Experimental Medicine·J P ManisF W Alt
Jun 23, 1998·Current Biology : CB·T LarocheS M Gasser
Sep 19, 1998·Molecular and Cellular Biology·R B WestM R Lieber
Jul 10, 1999·The Journal of Biological Chemistry·S Galande, T Kohwi-Shigematsu
Jul 20, 1999·The Journal of Biological Chemistry·A Bianchi, T de Lange
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·H VogelP Hasty
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·H L HsuD J Chen
Mar 1, 2000·Trends in Biochemical Sciences·L Aravind, E V Koonin
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·D O FergusonF W Alt
Sep 14, 2000·FEBS Letters·K SongI Lee
Nov 23, 2000·Genes & Development·H L HsuD J Chen

❮ Previous
Next ❯

Citations

Nov 26, 2015·International Journal of Molecular Sciences·Elzbieta Pawlowska, Janusz Blasiak
Dec 4, 2015·Cytokine·Nicole R LeitnerMathias Müller
Sep 30, 2015·Seminars in Cancer Biology·Suzanne J Randle, Heike Laman
Mar 29, 2016·Virology·Kathrin S RichterHolger Jeske
Apr 22, 2016·British Journal of Haematology·Arghya RayKenneth C Anderson
May 7, 2016·Acta Biochimica Et Biophysica Sinica·Yi-Li FengAn-Yong Xie
May 1, 2016·Biochimica Et Biophysica Acta·Anastasiya A KosovaOlga I Lavrik
Jun 23, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jan DimbergAndreas Matussek
Sep 14, 2016·Metabolism: Clinical and Experimental·Matem Tunçdemir, Melek Öztürk
Sep 11, 2016·Mechanisms of Ageing and Development·Stephan GasserFlorence S G Cheung
Sep 30, 2016·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Leon A Bach
Oct 22, 2016·Virology·Jasmine Rae FrostPeter Pelka
Dec 9, 2016·PLoS Genetics·Mélanie V LarcherRaymund J Wellinger
Nov 17, 2016·Scientific Reports·Victoria L FellCaroline Schild-Poulter
Jul 12, 2017·Pharmaceutical Patent Analyst·Hermann Am Mucke
Dec 20, 2017·Genes·Tapan Kumar MohantaHanhong Bae
Nov 29, 2017·Nucleic Acids Research·Shivlee NirwalDeepak T Nair
Oct 5, 2017·Physics in Medicine and Biology·Christian P Karger, Peter Peschke
Oct 1, 2015·Chembiochem : a European Journal of Chemical Biology·Fathima Shazna ThowfeikEdward Joseph Merino
Dec 6, 2018·Nucleic Acids Research·Pierre DupuyClaude Bruand
Jan 14, 2018·Scientific Reports·Shun SawatsubashiShigeo S Sugano
Jan 19, 2019·Cells·Petra Procházková SchrumpfováJiří Fajkus
Nov 6, 2018·Human Genetics·Svetlana A SmirnikhinaAlexander V Lavrov
Nov 21, 2016·G3 : Genes - Genomes - Genetics·Hexi ShenSylvia de Pater
Aug 30, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Li-Ya ChiuKyle M Miller
Aug 2, 2017·Annual Review of Cell and Developmental Biology·Serge PlazaFrançois Payre
Apr 17, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yong Jun ParkJoon Kim
Aug 4, 2016·Oncotarget·Curtis D HodgeJ N Mark Glover
Apr 29, 2020·Molecular and Cellular Biology·Seong Min Kim, Susan L Forsburg
Dec 22, 2016·Cellular and Molecular Life Sciences : CMLS·Claudia P Spampinato
Nov 5, 2017·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Junting CaiYutong Zhao
Apr 22, 2018·Cellular and Molecular Life Sciences : CMLS·Ignacio Campillo-Marcos, Pedro A Lazo
Aug 6, 2019·Frontiers in Oncology·Ismail S Mohiuddin, Min H Kang
May 31, 2016·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Charlene H Emerson, Alison A Bertuch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Genetics & Epigenetics of Aging

Dozens of genes are implicated in lifespan, and epigenetic changes during aging affect cell function. This feed focuses on the genetics and epigenetics of aging.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2021 Meta ULC. All rights reserved